Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 47 | 0 | 10 | 0 | €68.50 | €73.22 | 6.894% |
| Stryker Corp. | 23 | 0 | 6 | 0 | €305.10 | €335.03 | 9.809% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €402.10 | €408.36 | 1.556% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €216.30 | €294.01 | 35.927% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €723.60 | €771.54 | 6.625% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €293.30 | €298.90 | 1.908% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €159.24 | €200.06 | 25.633% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.58 | €86.77 | 40.908% |
| Align Technology | 15 | 2 | 4 | 0 | €257.50 | €345.95 | 34.350% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €550.20 | €568.09 | 3.252% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 4 | 0 | €898.80 | €958.32 | 6.622% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €69.00 | €84.52 | 22.494% |
| HCA Holdings Inc. | 22 | 0 | 4 | 0 | €300.40 | €305.49 | 1.695% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €150.54 | €174.43 | 15.872% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €202.80 | €207.72 | 2.424% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €52.44 | €78.42 | 49.547% |
| Humana Inc. | 23 | 0 | 3 | 0 | €319.00 | €439.88 | 37.892% |
| Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €82.87 | €88.17 | 6.395% |
| Pfizer Inc. | 30 | 4 | 2 | 0 | €26.49 | €40.66 | 53.490% |
| Intuitive Surgical Inc | 34 | 0 | 2 | 0 | €367.05 | €383.89 | 4.588% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €196.00 | €237.94 | 21.398% |
| Idexx Laboratories Inc. | 12 | 0 | 2 | 0 | €504.20 | €550.70 | 9.223% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €96.11 | €116.81 | 21.535% |
| UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €475.70 | €543.72 | 14.299% |
| Centene Corp. | 15 | 0 | 2 | 0 | €71.76 | €82.57 | 15.065% |